 LOS ALTOS, Calif., Sept. 7, 2021 PRNewswire -- Unicycive Therapeutics, Inc. Nasdaq: UNCY, a clinical stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D. 